A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer.
Am J Cancer Res
; 10(9): 3047-3060, 2020.
Article
in En
| MEDLINE
| ID: mdl-33042633
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Am J Cancer Res
Year:
2020
Type:
Article
Affiliation country:
United States